These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 16313279
21. Lamotrigine clinical pharmacokinetics. Rambeck B, Wolf P. Clin Pharmacokinet; 1993 Dec; 25(6):433-43. PubMed ID: 8119045 [Abstract] [Full Text] [Related]
23. A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder. Schieber FC, Boulton DW, Balch AH, Croop R, Mallikaarjun S, Benson J, Carlson BX. Hum Psychopharmacol; 2009 Mar; 24(2):145-52. PubMed ID: 19132712 [Abstract] [Full Text] [Related]
24. Development of an ultra-performance liquid chromatography-tandem mass spectrometry micromethod for quantification of lamotrigine in human plasma and its use in a bioequivalence trial. Marcelín-Jiménez G, P Angeles Moreno AC, Mendoza-Morales L, Rivera-Espinosa L, Martínez MM. Bioanalysis; 2009 Apr; 1(1):47-55. PubMed ID: 21083187 [Abstract] [Full Text] [Related]
25. The effect of raltegravir on the glucuronidation of lamotrigine. van Luin M, Colbers A, Verwey-van Wissen CP, van Ewijk-Beneken-Kolmer EW, van der Kolk M, Hoitsma A, da Silva HG, Burger DM. J Clin Pharmacol; 2009 Oct; 49(10):1220-7. PubMed ID: 19717722 [Abstract] [Full Text] [Related]
26. Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate. Della Paschoa OE, Voskuyl RA, Danhof M. Br J Pharmacol; 1998 Dec; 125(7):1610-6. PubMed ID: 9884091 [Abstract] [Full Text] [Related]
27. Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valproate or diazepam. Krupp E, Heynen T, Li XL, Post RM, Weiss SR. Exp Neurol; 2000 Apr; 162(2):278-89. PubMed ID: 10739634 [Abstract] [Full Text] [Related]
28. Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data. Hussein Z, Posner J. Br J Clin Pharmacol; 1997 May; 43(5):457-65. PubMed ID: 9159559 [Abstract] [Full Text] [Related]
29. Nicotine diminishes anticonvulsant activity of antiepileptic drugs in mice. Czuczwar M, Kiś J, Czuczwar P, Wielosz M, Turski W. Pol J Pharmacol; 2003 May; 55(5):799-802. PubMed ID: 14704477 [Abstract] [Full Text] [Related]
30. Pharmacokinetics of lamotrigine in patients with renal impairment: influence of haemodialysis. Fillastre JP, Taburet AM, Fialaire A, Etienne I, Bidault R, Singlas E. Drugs Exp Clin Res; 1993 May; 19(1):25-32. PubMed ID: 8223137 [Abstract] [Full Text] [Related]
31. Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo. Southam E, Pereira R, Stratton SC, Sargent R, Ford AJ, Butterfield LJ, Wheable JD, Beckett SR, Roe C, Marsden CA, Hagan RM. Eur J Pharmacol; 2005 Sep 20; 519(3):237-45. PubMed ID: 16129425 [Abstract] [Full Text] [Related]
32. Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. Franco V, Mazzucchelli I, Gatti G, Specchio LM, La Neve A, Papantonio A, Ozkaynakçi AE, Perucca E. Ther Drug Monit; 2008 Aug 20; 30(4):544-7. PubMed ID: 18641557 [Abstract] [Full Text] [Related]
33. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis. Luszczki JJ, Andres MM, Czuczwar P, Cioczek-Czuczwar A, Ratnaraj N, Patsalos PN, Czuczwar SJ. Epilepsia; 2006 Jan 20; 47(1):10-20. PubMed ID: 16417526 [Abstract] [Full Text] [Related]
34. The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects. Sidhu J, Job S, Singh S, Philipson R. Br J Clin Pharmacol; 2006 Feb 20; 61(2):191-9. PubMed ID: 16433873 [Abstract] [Full Text] [Related]
36. Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint. van Steeg TJ, Freijer J, Danhof M, de Lange EC. Br J Pharmacol; 2007 Jun 20; 151(3):356-66. PubMed ID: 17420778 [Abstract] [Full Text] [Related]
37. Single-dose pharmacokinetics of lamotrigine in children: influence of age and antiepileptic comedication. Battino D, Croci D, Granata T, Mamoli D, Messina S, Perucca E. Ther Drug Monit; 2001 Jun 20; 23(3):217-22. PubMed ID: 11360028 [Abstract] [Full Text] [Related]
38. Lack of interaction between sertraline and lamotrigine in psychiatric patients: a retrospective study. Christensen J, Sandgaard AP, Sidenius P, Linnet K, Licht RW. Pharmacopsychiatry; 2012 May 20; 45(3):119-21. PubMed ID: 22426846 [Abstract] [Full Text] [Related]
39. Intersex effect of lamotrigine on the pharmacokinetic parameters of CDRI-97/78, a novel trioxane antimalarial compound, in rats. Kushwaha HN, Gautam N, Misra A, Singh B, Kumar S, Siddiqui HH, Singh SK. Arzneimittelforschung; 2012 Jun 20; 62(6):274-9. PubMed ID: 22508175 [Abstract] [Full Text] [Related]
40. Does percent reduction in seizure frequency correlate with plasma concentration of anticonvulsant drugs? Experience with four anticonvulsant drugs. Mahmood I, Tammara VK, Baweja RK. Clin Pharmacol Ther; 1998 Nov 20; 64(5):547-52. PubMed ID: 9834047 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]